PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337615
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1337615
Personalized Nutrition Market Size and Share Analysis by Product Type, Application, End Use - Global Industry Demand Forecast to 2030
The personalized nutrition market was USD 11,142.4 million in 2022, and it will touch USD 33,658.5 million, advancing at a 14.8% CAGR, by 2030.
The growth of the industry is attributed to the increasing health consciousness, rising inclination toward active lifestyles among individuals, and surging number of businesses producing numerous tailored nutrition products, genetic testing kits, and apps.
The trend of offering personalized experiences is significantly rising with the shifting requirements of consumers. The need for customized nutrition solutions that utilized individual physical characteristics information to create nutritional advice, services, and products that suit their requirement is increasing continuously.
In 2022, the active measurement category, based on product type, held over 70% share of the industry, and it will propel at approximately 15% compound annual growth rate in the years to come.
The advancement in this category is because of the increasing customer consciousness regarding personalized test kits, mHealth apps, and diet plans.
The standard supplements category, based on application, which comprises both nutritional and health supplements, will advance at a 13% compound annual growth rate in the years to come. Standard supplements comprise multivitamins, minerals, botanicals, enzymes, amino acids, and herbs. Among these, one of the most common supplements that fill the gaps in nutrition is multivitamins.
Furthermore, with the surging elderly population, along with the increasing incidence of chronic diseases, the requirement for health supplements is expected to increase continuously. As a result, the standard supplements category will further propel at a remarkable rate in the year to come.
The direct-to-consumer category, based on end use, accounted for a significant personalized nutrition market share, of 40%, and it will lead the industry in the years to come. This is attributed to the rapid shifts in customers' preferences related to nutrition-rich supplements and products, to improve their well-being.
In 2022, the North American personalized nutrition industry held a significant share, of 40%, because of the increasing health consciousness, changing consumer preferences, the arrival of numerous industry players, and high purchasing power in the region.
As per a survey, multimineral/multivitamin supplements, omega-3 fatty acids, and vitamin D supplements are the most-common supplementary diet among all the people in the U.S. The survey also presented that the number of adults taking supplementary diets increases with the rising age. In addition, the consumption of personalized nutritional tablets is more in women as compared to men in the nation.
APAC is expected to observe the fastest growth in the years to come. This can be attributed to the increasing consciousness of health and the surging elderly population, along with the increasing incidence of chronic illnesses in the region.
With the increasing number of businesses producing customized nutrition products and apps, along with the surging inclination toward a healthy lifestyle, the personalized nutrition industry will continue to advance in the years to come.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end use
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
- 6.1. Market Dynamics
- 6.1.1. Trends
- 6.1.2. Drivers
- 6.1.3. Restraints/challenges
- 6.1.4. Impact analysis of drivers/restraints
- 6.2. Impact of COVID-19
- 6.3. Porter's Five Forces Analysis
- 6.3.1. Bargaining power of buyers
- 6.3.2. Bargaining power of suppliers
- 6.3.3. Threat of new entrants
- 6.3.4. Intensity of rivalry
- 6.3.5. Threat of substitutes
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Product Type (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by End Use (2017-2030)
- 7.5. Market Revenue, by Region (2017-2030)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Product Type (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by End Use (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Product Type (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by End Use (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. APAC Market
- 10.1. Overview
- 10.2. Market Revenue, by Product Type (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by End Use (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. LATAM Market
- 11.1. Overview
- 11.2. Market Revenue, by Product Type (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by End Use (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. MEA Market
- 12.1. Overview
- 12.2. Market Revenue, by Product Type (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by End Use (2017-2030)
- 12.5. Market Revenue, by Country (2017-2030)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Market Revenue, by Product Type (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by End Use (2017-2030)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Market Revenue, by Product Type (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by End Use (2017-2030)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Market Revenue, by Product Type (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by End Use (2017-2030)
Chapter 16. France Market
- 16.1. Overview
- 16.2. Market Revenue, by Product Type (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by End Use (2017-2030)
Chapter 17. U.K. Market
- 17.1. Overview
- 17.2. Market Revenue, by Product Type (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by End Use (2017-2030)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Market Revenue, by Product Type (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by End Use (2017-2030)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Market Revenue, by Product Type (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by End Use (2017-2030)
Chapter 20. Japan Market
- 20.1. Overview
- 20.2. Market Revenue, by Product Type (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by End Use (2017-2030)
Chapter 21. China Market
- 21.1. Overview
- 21.2. Market Revenue, by Product Type (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by End Use (2017-2030)
Chapter 22. India Market
- 22.1. Overview
- 22.2. Market Revenue, by Product Type (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by End Use (2017-2030)
Chapter 23. Australia Market
- 23.1. Overview
- 23.2. Market Revenue, by Product Type (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by End Use (2017-2030)
Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Market Revenue, by Product Type (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by End Use (2017-2030)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Market Revenue, by Product Type (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by End Use (2017-2030)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Market Revenue, by Product Type (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by End Use (2017-2030)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Market Revenue, by Product Type (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by End Use (2017-2030)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Market Revenue, by Product Type (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by End Use (2017-2030)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Market Revenue, by Product Type (2017-2030)
- 29.3. Market Revenue, by Application (2017-2030)
- 29.4. Market Revenue, by End Use (2017-2030)
Chapter 30. Competitive Landscape
- 30.1. List of Market Players and their Offerings
- 30.2. Competitive Benchmarking of Key Players
- 30.3. Product Benchmarking of Key Players
- 30.4. Recent Strategic Developments
Chapter 31. Company Profiles
- 31.1. BASF SE
- 31.1.1. Business overview
- 31.1.2. Product and service offerings
- 31.1.3. Key financial summary
- 31.2. Koninklijke DSM N.V.
- 31.2.1. Business overview
- 31.2.2. Product and service offerings
- 31.2.3. Key financial summary
- 31.3. Herbalife Nutrition Ltd.
- 31.3.1. Business overview
- 31.3.2. Product and service offerings
- 31.3.3. Key financial summary
- 31.4. Amway Corporation
- 31.4.1. Business overview
- 31.4.2. Product and service offerings
- 31.4.3. Key financial summary
- 31.5. Prenetics Limited
- 31.5.1. Business overview
- 31.5.2. Product and service offerings
- 31.5.3. Key financial summary
- 31.6. Nutrigenomix Inc.
- 31.6.1. Business overview
- 31.6.2. Product and service offerings
- 31.7. Viome Life Sciences Inc.
- 31.7.1. Business overview
- 31.7.2. Product and service offerings
- 31.8. Habit LLC
- 31.8.1. Business overview
- 31.8.2. Product and service offerings
- 31.9. Atlas Biomed Group Limited
- 31.9.1. Business overview
- 31.9.2. Product and service offerings
- 31.10. Abbott
- 31.10.1. Business overview
- 31.10.2. Product and service offerings
- 31.10.3. Key financial summary
- 31.11. Superior Supplement Manufacturing
- 31.11.1. Business overview
- 31.11.2. Product and service offerings
- 31.12. GX Sciences LLC
- 31.12.1. Business overview
- 31.12.2. Product and service offerings
- 31.13. Nutralliance
- 31.13.1. Business overview
- 31.13.2. Product and service offerings
- 31.14. Helix OpCo LLC
- 31.14.1. Business overview
- 31.14.2. Product and service offerings
- 31.15. Baze Labs Inc.
- 31.15.1. Business overview
- 31.15.2. Product and service offerings
Chapter 32. Appendix
- 32.1. Abbreviations
- 32.2. Sources and References
- 32.3. Related Reports
